230 related articles for article (PubMed ID: 1637881)
41. Myelofibrosis in chronic myeloproliferative disorders. Incidence among subtypes according to the Hannover Classification.
Buhr T; Georgii A; Choritz H
Pathol Res Pract; 1993 Mar; 189(2):121-32. PubMed ID: 8321741
[TBL] [Abstract][Full Text] [Related]
42. Histopathology of bone marrow in human chronic leukemias.
Georgii A
Haematol Blood Transfus; 1979; 23():59-70. PubMed ID: 296116
[TBL] [Abstract][Full Text] [Related]
43. [Thrombocytosis versus thrombocythemia--differential diagnosis of elevated platelet count].
Thiele J; Kvasnicka HM
Pathologe; 2000 Jan; 21(1):31-8. PubMed ID: 10663667
[TBL] [Abstract][Full Text] [Related]
44. [Chronic myeloproliferative diseases].
Verh Dtsch Ges Pathol; 1983; 67():214-75. PubMed ID: 6666266
[No Abstract] [Full Text] [Related]
45. Classification of myeloproliferative disorders by bone marrow histology.
Frisch B; Bartl R; Burkhardt R; Jäger K; Mahl G; Kettner G
Bibl Haematol; 1984; (50):57-80. PubMed ID: 6590039
[No Abstract] [Full Text] [Related]
46. Interferon-alfa corrects thrombocytosis in patients with myeloproliferative disorders.
Ludwig H; Linkesch W; Gisslinger H; Fritz E; Sinzinger H; Radaszkiewicz T; Chott A; Flener R; Micksche M
Cancer Immunol Immunother; 1987; 25(3):266-73. PubMed ID: 3677127
[TBL] [Abstract][Full Text] [Related]
47. Flow cytometric analysis of megakaryocyte ploidy in chronic myeloproliferative disorders and reactive thrombocytosis.
Jacobsson S; Carneskog J; Ridell B; Wadenvik H; Swolin B; Kutti J
Eur J Haematol; 1996 May; 56(5):287-92. PubMed ID: 8641402
[TBL] [Abstract][Full Text] [Related]
48. Potential of bone marrow biopsy in chronic myeloproliferative disorders (MPD).
Bartl R; Frisch B; Wilmanns W
Eur J Haematol; 1993 Jan; 50(1):41-52. PubMed ID: 8436214
[TBL] [Abstract][Full Text] [Related]
49. Human megakaryocytes. III. Characterization in myeloproliferative disorders.
Rabellino EM; Levene RB; Nachman RL; Leung LL
Blood; 1984 Mar; 63(3):615-22. PubMed ID: 6230121
[TBL] [Abstract][Full Text] [Related]
50. Hematopathologic findings in the myeloproliferative disorders.
Dickstein JI; Vardiman JW
Semin Oncol; 1995 Aug; 22(4):355-73. PubMed ID: 7638633
[TBL] [Abstract][Full Text] [Related]
51. [Anagrelide-induced changes of megakaryopoiesis during therapy of chronic myeloproliferative disorders with thrombocythemia].
Thiele J; Kvasnicka HM; Schmitt-Gräff A
Pathologe; 2002 Nov; 23(6):426-32. PubMed ID: 12436295
[TBL] [Abstract][Full Text] [Related]
52. Nucleolar organizer regions of megakaryocytes in chronic myeloproliferative disorders.
Matolcsy A; Nádor R; Wéber E; Kónya T
Virchows Arch A Pathol Anat Histopathol; 1992; 420(5):441-5. PubMed ID: 1375798
[TBL] [Abstract][Full Text] [Related]
53. Megakaryocyte-related interleukins in reactive thrombocytosis versus autonomous thrombocythemia.
Haznedaroğlu IC; Ertenli I; Ozcebe OI; Kiraz S; Ozdemir O; Sayinalp NM; Dündar SV; Calgüneri M; Kirazli S
Acta Haematol; 1996; 95(2):107-11. PubMed ID: 8638438
[TBL] [Abstract][Full Text] [Related]
54. Histologic criteria for classification and differential diagnosis of chronic myeloproliferative disorders.
Frisch B; Bartl R; Burkhardt R; Jäger K
Haematologia (Budap); 1984; 17(2):209-26. PubMed ID: 6534829
[TBL] [Abstract][Full Text] [Related]
55. The role of beta-catenin in chronic myeloproliferative disorders.
Jauregui MP; Sanchez SR; Ewton AA; Rice L; Perkins SL; Dunphy CH; Chang CC
Hum Pathol; 2008 Oct; 39(10):1454-8. PubMed ID: 18619646
[TBL] [Abstract][Full Text] [Related]
56. Classification and staging of Ph-negative myeloproliferative disorders by histopathology from bone marrow biopsies.
Georgii A; Buhr T; Buesche G; Kreft A; Choritz H
Leuk Lymphoma; 1996 Sep; 22 Suppl 1():15-29. PubMed ID: 8951769
[TBL] [Abstract][Full Text] [Related]
57. Megakaryocytes emperipolesis in bone marrow of the patients with non-Hodgkin's lymphoma.
Dziecioł J; Lemancewicz D; Kłoczko J; Bogusłowicz W; Lebelt A
Folia Histochem Cytobiol; 2001; 39 Suppl 2():142-3. PubMed ID: 11820577
[TBL] [Abstract][Full Text] [Related]
58. Reproducibility of histologic classification in nonfibrotic myeloproliferative neoplasia.
Koopmans SM; Bot FJ; Lam KH; van Marion AM; de Raeve H; Hebeda KM
Am J Clin Pathol; 2011 Oct; 136(4):618-24. PubMed ID: 21917685
[TBL] [Abstract][Full Text] [Related]
59. The myeloproliferative disorders. An historical appraisal and personal experiences.
Michiels JJ
Leuk Lymphoma; 1996 Sep; 22 Suppl 1():1-14. PubMed ID: 8951768
[TBL] [Abstract][Full Text] [Related]
60. Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).
Michiels JJ; Bernema Z; Van Bockstaele D; De Raeve H; Schroyens W
Pathol Biol (Paris); 2007 Mar; 55(2):92-104. PubMed ID: 16919893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]